Bill of Health
MAY 22, 2023
The selections feature topics ranging from an analysis of government and industry investments for recently approved drugs, to a discussion of court decisions on mifepristone, and an examination of the added therapeutic benefit associated with the top-selling brand-name drugs in Medicare. JAMA Health Forum. 2023 Apr 7;4(4):e230511.
Health Populi
OCTOBER 28, 2019
patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. Over one-half of Americans blame pharmaceutical companies as most responsible for the opioid crisis, followed by physicians, whom 39% of health consumers blame, and patients, whom 38% of people blame. Exacerbating U.S.
Kaiser Health News
APRIL 22, 2022
A 2020 study found that the list price of insulin products increased by 262% from 2007 to 2018, while a 2021 study found that from 2014 to 2018 the list price of insulin products increased by 40%. However, the pharmaceutical industry disagrees with this assessment. Is there a reason the price has ballooned?
Expert insights. Personalized for you.
157 
Let's personalize your content